Thursday, May 24, 2018
The LAM Foundation and the NCATS/NIH Rare Lung Diseases Consortium hope you will join us for the 2018 International Rare Lung Diseases Research Conference, to be held in Cincinnati, Ohio, on September 6-9, 2018. RLDC·2018 is designed to advance rare lung disease research by fostering scientific communication and collaboration, improving clinician knowledge about new diagnostics and therapeutics, and increasing patient understanding about diseases affecting them. For 2018, the conference theme is “Bringing Cutting Edge Technologies to Rare Lung Disease Research”. For more information about the conference, please visit https://www.thelamfoundation.org/conference.
Submitted abstracts will be reviewed by conference chairs and selected for platform or poster presentations based on scientific merit and alignment with session themes. The objective of the poster session is to provide a state-of-the-art overview of research progress in rare lung diseases including lymphangioleiomyomatosis, pulmonary alveolar proteinosis, Langerhans cell histiocytosis, generalized lymphatic anomalies, Hermansky Pudlak Syndrome, and Alpha-1 antitrypsin deficiency, to name a few. Studies on basic and translational science, and clinical aspects of all rare lung diseases are welcome.
To submit an abstract, visit the UC Abstract Submission Portal at https://bit.ly/2HbUHIQ.
SUBMISSION: The deadline for ABSTRACTS is midnight EDT on June 15, 2018. You will be asked to include a 300 word abstract, 100 word biography and a photo.
